Drug Discovery Digital 2020 - Connect - Learn - Discover

Overview


Welcome to Drug Discovery Digital

Due to the restrictions imposed by the global COVID-19 pandemic, ELRIG’s flagship conference Drug Discovery, now in its 14th year, will be a virtual event.

Taking place over a 2 week period from 6 – 16 October 2020, you can now enjoy the usual world-class science and exhibition you would expect from our flagship conference but from the comfort of your own desktop to fit with your daily schedule!

As with every year, however, Drug Discovery Digital will still include cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 50 world-class speakers with 8 main session tracks and 2 plenary keynote speakers. The tracks for 2020 are:

Better Hits = Better therapeutics?
Innovations in Chemistry to discover new medicines
GPCRs in drug discovery hosted by the British Pharmacological Society
Addressing the challenges of Infection – how do we develop new treatments?
Patient relevant models for drug discovery
Multi Omic approaches to deliver new medicines
Cancer Research UK track
New Modalities to treat disease

Drug Discovery has become the largest meeting of life sciences industry professionals in the UK and we plan on making this the largest virtual drug discovery event in the UK .

This event will bring together delegates and exhibiting companies from around the world in a virtual conference that will highlight the latest ground-breaking research, discuss cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel chemical and biological candidate drugs.

Plenary Keynote Speakers

Darrin Disley (Mogrify)
Professor Sarah J Tabrizi (UCL)

We have several sponsorship opportunities available to our vendors that can provide a wide range of new and exciting benefits for your organisation. We are also happy to discuss a tailored package to suit your budget.


Venue: Web Event
Organiser Contact Details:
ELRIG UK

T: 07484 113971
info@elrig.org

Delegates Registration


Press Releases


Download Download
Alexander
Dr Steve Alexander
University of Nottingham
Speaker
Alfa
Ron Alfa
Recursion
Speaker
Al-Hajj
Muhammad Al-Hajj
 Autolus
Speaker
Andrews
Dr David Andrews
Director of Pre-clinical Scientific Alliances
AstraZeneca
Speaker
Blakey
Dr David Blakey
Chief Scientific Officer
MiNA Therapeutics
Speaker
Burnham
Dr Katie Burnham
Postdoctoral Fellow
Sanger Institute
Speaker
Cebola 
Dr Ines Cebola 
Imperial College London
Speaker
Champion
Dr Olivia Champion
Biosystems Technology
Speaker
Chung
Dr Chun-wa Chung
UK Director of Structural and Biophysical Sciences
GSK R&D
Speaker
Collen
Anna Collen
Senior Project Director early CVRM
AstraZeneca
Speaker
Das
Shampa Das
University of Liverpool
Speaker
Davies
Gareth Davies
Associate Principal Scientist
AstraZeneca
Speaker
Davis
Jeremy Davis
UCB
Speaker
Dawson
Dr Michael Dawson
Director
Mike Dawson Antimicrobial Research Consultancy Ltd.
Speaker
Disley OBE
Dr Darrin M Disley OBE
Chief Executive Officer
Mogrify Limited
Speaker
Dowell
Dr Simon Dowell
Head, Human Biological Sample Management
GlaxoSmithKline
Speaker
Drewes
Dr Gerard Drewes
Global Head, Genome Editing Technologies
GlaxoSmithKline
Speaker
Drewry
Dr David Drewry
UNC Eshelman School of Pharmacy
Speaker
Duncan
Elaine Duncan
Scientist
Charles River Laboratories
Speaker
Erkstam
Dr Anna Erkstam
COO
BioReperia AB
Speaker
Fairhead
Heather Fairhead
Phico Therapeutics
Speaker
Finn
Paul Finn
Oxford Drug Design
Speaker
Foster
Keith Foster
University of Reading/Sutura Therapeutics
Speaker
Honarnejad
Dr Saman Honarnejad
Director Drug Discovery
Pivot Park Screening Centre
Speaker
Huber
Dr Wolfgang Huber
Research Group Leader
EMBL
Speaker
Jinks
Tim Jinks
Wellcome Trust
Speaker
Jumde
Dr Ravindra Jumde
Postdoctoral Researcher
Helmholtz Centre for Infection Research
Speaker
Kaja
Dr Simon Kaja
Chief Scientific Officer & Vice-President, Americas
Experimentica Ltd.
Speaker
Kaneider
Dr Nicole Kaneider
University of Cambridge
Speaker
Kendrew
Mrs Jane Kendrew
Director of Translational Oncology
Sygnature Discovery
Speaker
Kettleborough
Catherine Kettleborough
LifeArc
Speaker
Leeson
Paul Leeson
Paul Leeson Consulting
Speaker
Leveridge
Melanie Leveridge
GlaxoSmithKline
Speaker
Lundbäck
Dr Thomas Lundbäck
Associate Director
Discovery Sciences, AstraZeneca
Speaker
Marston
Dr Fiona Marston
Director
LSTM
Speaker
Milligan
Prof Graeme Milligan
University of Glasgow
Speaker
Morrow
Michelle Morrow
F-star
Speaker
Nelson
Adam Nelson
University of Leeds
Speaker
Nurmi
Dr Antti Nurmi
Managing Director
Charles River Discovery Services Finland
Speaker
O'Connell
Dr James O'Connell
Director
UCB
Speaker
Pfleger
Prof Kevin Pfleger
Director Biomedical Innovation
University of Western Australia
Speaker
Pijacka
Dr Wioletta Pijacka
Project Leader
RenaSci
Speaker
Powell
Dr David Powell
Chief Scientific Officer
Summit Therapeutics Plc
Speaker
Russell
Prof Graham Russell
University of Oxford
Speaker
Seashore-Ludlow
Mrs Brinton Seashore-Ludlow
Assistant Professor
Karolinska Institutet
Speaker
Snijder
Prof Berend Snijder
Assistant Professor
ETH Zurich
Speaker
Srivastava
Dr Prashant Srivastava
Imperial College London
Speaker
St Denis
Dr Jeffrey St Denis
Senior Research Associate
Astex Therapeutics
Speaker
Tabrizi
Prof Sarah Tabrizi
Director, Huntington's Disease Centre
UCL Queen Square Institute of Neurology
Speaker
Toboso-Navasa
Dr Amparo Toboso-Navasa
BAI
Speaker
Trezise
Del Trezise
Sartorius
Speaker
Waddell
Ian Waddell
Charles River Laboratories
Speaker

Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020